新生儿糖尿病：诊断与管理的最新进展
Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.
作者信息
Lemelman Michelle Blanco, Letourneau Lisa, Greeley Siri Atma W
机构信息
Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, MC 5053, 5841 South Maryland Avenue, Chicago, IL 60637, USA.
Monogenic Diabetes Registry, University of Chicago Medicine, Kovler Diabetes Center, 900 East 57th Street, Chicago, IL 60637, USA.
出版信息
Clin Perinatol. 2018 Mar;45(1):41-59. doi: 10.1016/j.clp.2017.10.006. Epub 2017 Dec 16.
Abstract
Neonatal diabetes mellitus is likely to be due to an underlying monogenic defect when it occurs at less than 6 months of age. Early recognition and urgent genetic testing are important for predicting the clinical course and raising awareness of possible additional features. Early treatment of sulfonylurea-responsive types of neonatal diabetes may improve neurologic outcomes. It is important to distinguish neonatal diabetes mellitus from other causes of hyperglycemia in newborns. Other causes include infection, stress, inadequate pancreatic insulin production in preterm infants, among others. This review explores the diagnostic approach, mutation types, management, and clinical course of neonatal diabetes.
摘要
新生儿糖尿病若在6个月龄之前发病，很可能是由潜在的单基因缺陷所致。早期识别和紧急基因检测对于预测临床病程以及提高对可能存在的其他特征的认识非常重要。对磺脲类药物敏感型的新生儿糖尿病进行早期治疗可能会改善神经学预后。区分新生儿糖尿病与新生儿高血糖的其他病因很重要。其他病因包括感染、应激、早产儿胰腺胰岛素分泌不足等。本综述探讨了新生儿糖尿病的诊断方法、突变类型、管理及临床病程。
相似文献
1
Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.新生儿糖尿病：诊断与管理的最新进展
Clin Perinatol. 2018 Mar;45(1):41-59. doi: 10.1016/j.clp.2017.10.006. Epub 2017 Dec 16.
2
Remission of severe neonatal diabetes with very early sulfonylurea treatment.极早期使用磺脲类药物治疗严重新生儿糖尿病的缓解情况。
Diabetes Care. 2015 Mar;38(3):e38-9. doi: 10.2337/dc14-2124.
3
Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.病例报告：亡羊补牢，为时未晚，但早做更好：两名 KCNJ11 变异致新生儿糖尿病患者由 CSII 转用磺脲类药物。
Front Endocrinol (Lausanne). 2023 May 11;14:1143736. doi: 10.3389/fendo.2023.1143736. eCollection 2023.
4
Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.极早早产儿合并短暂性新生儿糖尿病的个性化精准医疗
J Pediatr Endocrinol Metab. 2017 May 1;30(5):593-596. doi: 10.1515/jpem-2016-0261.
5
[Neonatal diabetes mellitus].[新生儿糖尿病]
Duodecim. 2011;127(6):534-41.
6
Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.一名因KCNJ11 F333L[已修正]突变导致单基因新生儿糖尿病的患者成功从胰岛素治疗过渡到磺脲类药物治疗。
Diabetes Care. 2013 Dec;36(12):e201. doi: 10.2337/dc13-1690.
7
[Neonatal diabetes mellitus: treatment with sulfonylurea in a preterm born infant].[新生儿糖尿病：对一名早产婴儿使用磺脲类药物治疗]
Klin Padiatr. 2009 Mar-Apr;221(2):100. doi: 10.1055/s-0029-1202867. Epub 2009 Mar 4.
8
ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.ATP敏感性钾通道——新生儿糖尿病及其他情况
N Engl J Med. 2006 Aug 3;355(5):507-10. doi: 10.1056/NEJMe068142.
9
Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.成功应用磺酰脲类药物治疗 1 例因 ABCC8 基因突变 p.P1199L 导致的新生儿糖尿病患儿
J Perinatol. 2012 Aug;32(8):645-7. doi: 10.1038/jp.2012.46.
10
Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital.越南国家儿童医院的 K-通道新生儿糖尿病的分子遗传学、临床特征和治疗结果。
Front Endocrinol (Lausanne). 2021 Sep 9;12:727083. doi: 10.3389/fendo.2021.727083. eCollection 2021.
引用本文的文献
1
De Novo KCNJ11 Mutation in an Infant With Neonatal Diabetes Mellitus Presenting as Diabetic Ketoacidosis: A Case Report and Literature Review.一名以糖尿病酮症酸中毒为表现的新生儿糖尿病婴儿的新发KCNJ11突变：病例报告及文献综述
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251368092. doi: 10.1177/23247096251368092. Epub 2025 Aug 21.
2
Prenatal pembrolizumab exposure as the potential link among recurrent necrotizing enterocolitis, neonatal diabetes mellitus and exocrine pancreatic insufficiency: a case report.产前暴露于帕博利珠单抗作为复发性坏死性小肠结肠炎、新生儿糖尿病和外分泌性胰腺功能不全之间的潜在联系：一例报告
Ital J Pediatr. 2025 Jul 18;51(1):237. doi: 10.1186/s13052-025-02021-8.
3
Successful Treatment of a Very Low-Birth-Weight Infant With GATA6 Neonatal Diabetes Using Continuous Subcutaneous Insulin Infusion.使用持续皮下胰岛素输注成功治疗一名患有GATA6新生儿糖尿病的超低出生体重婴儿。
Cureus. 2025 May 6;17(5):e83555. doi: 10.7759/cureus.83555. eCollection 2025 May.
4
Case Report: Challenges of insulin and sulfonylurea dosing in an extremely premature infant for the management of KCNJ11-associated neonatal diabetes mellitus.病例报告：极低出生体重儿中胰岛素和磺脲类药物剂量调整对KCNJ11相关新生儿糖尿病的管理挑战
Front Pediatr. 2025 Apr 16;13:1456818. doi: 10.3389/fped.2025.1456818. eCollection 2025.
5
Real world evidence of insulin and biosimilar insulin therapy-Opportunities to improve adherence, outcomes and cost-effectiveness.胰岛素及生物类似物胰岛素治疗的真实世界证据——改善依从性、治疗效果和成本效益的机遇
Diabetes Obes Metab. 2025 Apr 15. doi: 10.1111/dom.16386.
6
Diagnosis and Treatment of Neonatal Diabetes Caused by ATP-Channel Mutations: Genetic Insights, Sulfonylurea Therapy, and Future Directions.ATP通道突变所致新生儿糖尿病的诊断与治疗：遗传学见解、磺脲类药物治疗及未来方向
Children (Basel). 2025 Feb 12;12(2):219. doi: 10.3390/children12020219.
7
Monogenic Familial Neonatal Diabetes in Preterm Infant With Gene Mutation: Transition to Oral Sulfonylurea Therapy.具有基因突变的早产儿单基因家族性新生儿糖尿病：向口服磺脲类药物治疗的转变
J Pediatr Pharmacol Ther. 2025 Feb;30(1):129-132. doi: 10.5863/1551-6776-30.1.129. Epub 2025 Feb 10.
8
Genetic Structure of Hereditary Forms of Diabetes Mellitus in Russia.俄罗斯遗传性糖尿病的遗传结构
Int J Mol Sci. 2025 Jan 16;26(2):740. doi: 10.3390/ijms26020740.
9
Evaluation of criterion-based audit in improving quality of neonatal birth asphyxia care at Balaka district hospital in Malawi.在马拉维巴拉卡区医院评估基于标准的审计对改善新生儿出生窒息护理质量的作用。
Matern Health Neonatol Perinatol. 2024 Nov 4;10(1):21. doi: 10.1186/s40748-024-00191-7.
10
Successful Transition to Sulfonylurea for Relapsed Monogenic Diabetes Due to Rare 6q23.3 Duplication.因罕见的6q23.3重复导致复发性单基因糖尿病成功过渡至磺脲类药物治疗。
JCEM Case Rep. 2024 Oct 16;2(10):luae180. doi: 10.1210/jcemcr/luae180. eCollection 2024 Oct.
本文引用的文献
1
Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis.婴儿期糖尿病的表现：糖尿病酮症酸中毒的高风险
Diabetes Care. 2017 Oct;40(10):e147-e148. doi: 10.2337/dc17-1145. Epub 2017 Aug 4.
2
ABM Clinical Protocol #27: Breastfeeding an Infant or Young Child with Insulin-Dependent Diabetes.ABM临床方案#27：为患有胰岛素依赖型糖尿病的婴幼儿哺乳。
Breastfeed Med. 2017 Mar;12:72-76. doi: 10.1089/bfm.2017.29035.djm. Epub 2017 Jan 30.
3
ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes.与 KCNJ11 相关的新生儿糖尿病相关的 ADHD、学习困难和睡眠障碍。
Pediatr Diabetes. 2017 Nov;18(7):518-523. doi: 10.1111/pedi.12428. Epub 2016 Aug 24.
4
Prematurity and Genetic Testing for Neonatal Diabetes.早产与新生儿糖尿病的基因检测
Pediatrics. 2016 Sep;138(3). doi: 10.1542/peds.2015-3926. Epub 2016 Aug 18.
5
Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls.与同胞对照相比，患有与KCNJ11相关糖尿病的患者经常存在神经心理障碍。
Diabet Med. 2016 Oct;33(10):1380-6. doi: 10.1111/dme.13159. Epub 2016 Jun 22.
6
Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes.1型糖尿病遗传风险评分：一种区分单基因糖尿病和1型糖尿病的新工具。
Diabetes. 2016 Jul;65(7):2094-2099. doi: 10.2337/db15-1690. Epub 2016 Apr 5.
7
Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.KCNJ11型新生儿糖尿病成功转换为使用磺脲类药物治疗取决于突变情况和糖尿病病程。
Diabetologia. 2016 Jun;59(6):1162-6. doi: 10.1007/s00125-016-3921-8. Epub 2016 Mar 31.
8
Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach.采用下一代测序与多重连接探针扩增技术相结合的方法改善新生儿糖尿病患者的分子诊断。
J Pediatr Endocrinol Metab. 2016 May 1;29(5):523-31. doi: 10.1515/jpem-2015-0341.
9
Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.1岁以下新生儿及婴儿的持续皮下胰岛素输注：基于德国儿科泵治疗工作组经验的初始推注量和基础输注率分析
Diabetes Technol Ther. 2015 Dec;17(12):872-9. doi: 10.1089/dia.2015.0030. Epub 2015 Oct 28.
10
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.磺酰脲类药物治疗钾通道突变导致的新生儿糖尿病患者的神经和精神运动功能有益。
Diabetes Care. 2015 Nov;38(11):2033-41. doi: 10.2337/dc15-0837. Epub 2015 Oct 5.
Zotero 插件